Leptomycin A structure
|
Common Name | Leptomycin A | ||
---|---|---|---|---|
CAS Number | 87081-36-5 | Molecular Weight | 526.70400 | |
Density | 1.079g/cm3 | Boiling Point | 717.7ºC at 760 mmHg | |
Molecular Formula | C32H46O6 | Melting Point | N/A | |
MSDS | USA | Flash Point | 224.2ºC | |
Symbol |
GHS02, GHS06, GHS08 |
Signal Word | Danger |
Use of Leptomycin ALeptomycin A, a Streptomyces metabolite, is an inhibitor of CRM1 (exportin 1) that blocks CRM1 interaction with nuclear export signals, preventing the nuclear export of a broad range of proteins. Leptomycin A suppresses HIV-1 replication. Less potent than Leptomycin B[1][2]. |
Name | leptomycin A |
---|---|
Synonym | More Synonyms |
Description | Leptomycin A, a Streptomyces metabolite, is an inhibitor of CRM1 (exportin 1) that blocks CRM1 interaction with nuclear export signals, preventing the nuclear export of a broad range of proteins. Leptomycin A suppresses HIV-1 replication. Less potent than Leptomycin B[1][2]. |
---|---|
Related Catalog | |
Target |
CRM1[1][2]. |
References |
Density | 1.079g/cm3 |
---|---|
Boiling Point | 717.7ºC at 760 mmHg |
Molecular Formula | C32H46O6 |
Molecular Weight | 526.70400 |
Flash Point | 224.2ºC |
Exact Mass | 526.32900 |
PSA | 100.90000 |
LogP | 6.39460 |
Index of Refraction | 1.544 |
Storage condition | ?20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Symbol |
GHS02, GHS06, GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H225-H301 + H311 + H331-H370 |
Precautionary Statements | P210-P260-P280-P301 + P310-P311 |
Hazard Codes | F,T |
Risk Phrases | 11-23/24/25-39/23/24/25 |
Safety Phrases | 16-36/37-45 |
RIDADR | UN 1230 3/PG 2 |
Serine residue 115 of MAPK-activated protein kinase MK5 is crucial for its PKA-regulated nuclear export and biological function.
Cell. Mol. Life Sci. 68 , 847-62, (2011) The mitogen-activated protein kinase-activated protein kinase-5 (MK5) resides predominantly in the nucleus of resting cells, but p38(MAPK), extracellular signal-regulated kinases-3 and -4 (ERK3 and ER... |
|
Leptomycins A and B, new antifungal antibiotics. I. Taxonomy of the producing strain and their fermentation, purification and characterization.
J. Antibiot. 36(6) , 639-45, (1983) A strain of Streptomyces was found to produce new antifungal antibiotics. The active compounds were purified and separated into two substances named leptomycin A and B by high performance liquid chrom... |
|
Leptomycins A and B, new antifungal antibiotics. II. Structure elucidation.
J. Antibiot. 36(6) , 646-50, (1983) The structures of new antifungal antibiotics, leptomycins A and B produced by Streptomyces sp. ATS1287 were determined as described below (Fig. 1) on the basis of their spectral and chemical character... |
(2E,10E,12E,16E,18E)-6-hydroxy-3,5,7,9,11,15,17-heptamethyl-19-(3-methyl-6-oxo-2,3-dihydropyran-2-yl)-8-oxononadeca-2,10,12,16,18-pentaenoic acid |
2,10,12,16,18-Nonadecapentaenoic acid,19-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-3,5,7,9,11,15,17-heptamethyl-6-hydroxy-8-oxo |
C32H46O6 |
2,10,12,16,18-Nonadecapentaenoic acid,19-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-6-hydroxy-3,5,7,9,11,15,17-heptamethyl-8-oxo |
Leptomycin A |
Jildamycin |